載入...
Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study
BACKGROUND: Biomarkers that can be used to accurately assess the residual risk of disease recurrence in women with hormone receptor–positive breast cancer are clinically valuable. We evaluated the prognostic value of the Breast Cancer Index (BCI), a continuous risk index based on a combination of HO...
Na minha lista:
| 發表在: | Breast Cancer Res |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4700696/ https://ncbi.nlm.nih.gov/pubmed/26728744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-015-0660-6 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|